Vernakalant for the conversion of atrial fibrillation: The new kid on the block?
Guardado en:
| Autores principales: | , |
|---|---|
| Formato: | JOUR |
| Materias: | |
| Acceso en línea: | http://hdl.handle.net/20.500.12110/paper_1082720X_v19_n4_p299_Conde |
| Aporte de: |
| id |
todo:paper_1082720X_v19_n4_p299_Conde |
|---|---|
| record_format |
dspace |
| spelling |
todo:paper_1082720X_v19_n4_p299_Conde2023-10-03T16:04:02Z Vernakalant for the conversion of atrial fibrillation: The new kid on the block? Conde, D. Baranchuk, A. atrial fibrillation pharmacological cardioversion vernakalant vernakalant anisole derivative antiarrhythmic agent pyrrolidine derivative vernakalant bradycardia cardiogenic shock cardioversion drug safety heart atrium fibrillation human hypotension patient safety priority journal review sinus rhythm Atrial Fibrillation randomized controlled trial (topic) Anisoles Anti-Arrhythmia Agents Atrial Fibrillation Humans Pyrrolidines Randomized Controlled Trials as Topic JOUR info:eu-repo/semantics/openAccess http://creativecommons.org/licenses/by/2.5/ar http://hdl.handle.net/20.500.12110/paper_1082720X_v19_n4_p299_Conde |
| institution |
Universidad de Buenos Aires |
| institution_str |
I-28 |
| repository_str |
R-134 |
| collection |
Biblioteca Digital - Facultad de Ciencias Exactas y Naturales (UBA) |
| topic |
atrial fibrillation pharmacological cardioversion vernakalant vernakalant anisole derivative antiarrhythmic agent pyrrolidine derivative vernakalant bradycardia cardiogenic shock cardioversion drug safety heart atrium fibrillation human hypotension patient safety priority journal review sinus rhythm Atrial Fibrillation randomized controlled trial (topic) Anisoles Anti-Arrhythmia Agents Atrial Fibrillation Humans Pyrrolidines Randomized Controlled Trials as Topic |
| spellingShingle |
atrial fibrillation pharmacological cardioversion vernakalant vernakalant anisole derivative antiarrhythmic agent pyrrolidine derivative vernakalant bradycardia cardiogenic shock cardioversion drug safety heart atrium fibrillation human hypotension patient safety priority journal review sinus rhythm Atrial Fibrillation randomized controlled trial (topic) Anisoles Anti-Arrhythmia Agents Atrial Fibrillation Humans Pyrrolidines Randomized Controlled Trials as Topic Conde, D. Baranchuk, A. Vernakalant for the conversion of atrial fibrillation: The new kid on the block? |
| topic_facet |
atrial fibrillation pharmacological cardioversion vernakalant vernakalant anisole derivative antiarrhythmic agent pyrrolidine derivative vernakalant bradycardia cardiogenic shock cardioversion drug safety heart atrium fibrillation human hypotension patient safety priority journal review sinus rhythm Atrial Fibrillation randomized controlled trial (topic) Anisoles Anti-Arrhythmia Agents Atrial Fibrillation Humans Pyrrolidines Randomized Controlled Trials as Topic |
| format |
JOUR |
| author |
Conde, D. Baranchuk, A. |
| author_facet |
Conde, D. Baranchuk, A. |
| author_sort |
Conde, D. |
| title |
Vernakalant for the conversion of atrial fibrillation: The new kid on the block? |
| title_short |
Vernakalant for the conversion of atrial fibrillation: The new kid on the block? |
| title_full |
Vernakalant for the conversion of atrial fibrillation: The new kid on the block? |
| title_fullStr |
Vernakalant for the conversion of atrial fibrillation: The new kid on the block? |
| title_full_unstemmed |
Vernakalant for the conversion of atrial fibrillation: The new kid on the block? |
| title_sort |
vernakalant for the conversion of atrial fibrillation: the new kid on the block? |
| url |
http://hdl.handle.net/20.500.12110/paper_1082720X_v19_n4_p299_Conde |
| work_keys_str_mv |
AT conded vernakalantfortheconversionofatrialfibrillationthenewkidontheblock AT baranchuka vernakalantfortheconversionofatrialfibrillationthenewkidontheblock |
| _version_ |
1782028977691426816 |